GlassScriptPhysician profile
Ravi Kanagala
NPI 1124009220
$13,782.35
in general payments reported to CMS, 2019-2025
26 companies · $2,817 in 2025
The $2,817 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $677 · 2021: $1,643 · 2022: $3,710 · 2023: $1,780 · 2024: $2,253 · 2025: $2,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,216 · Travel and Lodging: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,216.43 |
| Travel and Lodging | $633.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,593.69 | 2021-2025 | Linq II, Azure Xt Dr Mri Surescan, Micra |
| Atricure, INC. | $1,785.20 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbott Laboratories | $1,675.89 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Boston Scientific Corporation | $981.15 | 2019-2024 | Watchman Access System, Bodyguardian |
| Medtronic Vascular, INC. | $715.35 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $532.38 | 2022-2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $272.08 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $212.44 | 2019-2023 | Eliquis |
| Zoll Respicardia, INC. | $163.27 | 2023 | Remede System |
| Baxter Healthcare | $112.41 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Ebr Systems, INC. | $89.23 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.79 | 2020-2025 | Lifevest |
| Itamar Medical INC | $82.15 | 2023 | Watchpatone |
| Novo Nordisk INC | $81.12 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Impulse Dynamics (USA) INC. | $77.11 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $63.14 | 2022 | |
| Z-Medica, LLC | $39.44 | 2020 | |
| Pfizer INC. | $32.38 | 2023 | |
| Biosense Webster, INC. | $31.42 | 2019 | |
| Cardiofocus, INC. | $30.22 | 2021-2022 | |
| Abbvie INC. | $30.18 | 2020-2023 | |
| Irhythm Technologies, INC. | $24.36 | 2024 | Zio Monitor, Zio Xt Patch |
| Astellas Pharma US INC | $19.92 | 2019 | |
| Teleflex LLC | $17.84 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.23 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Kanagala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.